---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-24-000096"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:54:02.347253+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Chemed Q1 2024: Adjusted EPS $5.20 beats; VITAS EBITDA surges 67%, Roto-Rooter down 16%

## Summary
- Revenue +5.2% to $589.2M; GAAP EPS $4.24 (+18.4%); Adjusted EPS $5.20 (+21.5%)
- VITAS net patient revenue +14% to $354M, ADC up 10.3% to 19,665; adjusted EBITDA +67.2% to $60.7M
- Roto-Rooter revenue -5.8% to $235.2M, adjusted EBITDA -15.6% to $60.7M; margin down 299bps
- Acquired Covenant Health hospice assets for $85M on Apr 17; no debt, $313.4M cash; bought back 50k shares for $32.3M
- Full-year 2024 adjusted EPS guidance reaffirmed at $23.30-$23.70; next update with Q2 results

## SEC filing metadata
- accession: 0001562762-24-000096
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276224000096/0001562762-24-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276224000096/che-20240424x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-24-000096
- JSON: https://secwatch.observer/filing/0001562762-24-000096.json
- Plain text: https://secwatch.observer/filing/0001562762-24-000096.txt

## Key facts
- Earnings Releases
  CHEMED CORP reported first quarter ended March 31, 2024 results: revenue $589.2 million, EPS $4.24.
  - Period: first quarter ended March 31, 2024
  - Revenue: $589.2 million
  - EPS: $4.24
  - Result: reported results
  source text: · Revenue increased 5.2% to $589.2 million · GAAP Diluted Earnings-per-Share (EPS) of $4.24, an increase of 18.4% · Adjusted Diluted EPS of $5.20, an increase of 21.5%
  evidence_url: https://www.sec.gov/Archives/edgar/data/19584/000156276224000096/0001562762-24-000096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.